141
Views
1
CrossRef citations to date
0
Altmetric
Research Article

LncRNA-NEAT1 inhibits the occurrence and development of pancreatic cancer through spongy miR-146b-5p/traf6

, , , , , & show all
Received 20 Feb 2023, Accepted 13 Mar 2023, Published online: 23 Mar 2023

References

  • Abbastabar, M., Sarfi, M., Golestani, A., & Khalili, E. (2018). lncRNA involvement in hepatocellular carcinoma metastasis and prognosis. EXCLI Journal, 17(1611–2156), 900.
  • Abolfathi, H., Sheikhpour, M., Soltani, B. M., & Fahimi, H. (2021). The comparison and evaluation of the miR-16, miR-155 and miR-146a expression pattern in the blood of TB and NSCLC patients: A research paper. Gene Reports, 22(2452–0144), 100967.
  • Cheng, M., Yang, Y., Xin, H., Li, M., Zong, T., He, X., Yu, T., & Xin, H. (2020). Non‐coding RNAs in aortic dissection: From biomarkers to therapeutic targets. Journal of Cellular and Molecular Medicine, 24(20), 11622–11637.
  • Chen, F., Wang, N., Tan, H. Y., Guo, W., Zhang, C., & Feng, Y. (2019). The functional roles of exosomes-derived long non-coding RNA in human cancer. Cancer Biology & Therapy, 20(5), 583–592.
  • Del Vecchio, F., Lee, G. H., Hawezi, J., Bhome, R., Pugh, S., Sayan, E., Thomas, G., Packham, G., Primrose, J., Pichler, M., Mirnezami, A., Calin, G., & Bullock, M. (2018). Long non-coding RNAs within the tumour microenvironment and their role in tumour-stroma cross-talk. Cancer Letters, 421, 94–102. https://doi.org/10.1016/j.canlet.2018.02.022
  • Ding, J., Zhang, Y., Cai, X., Zhang, Y., Yan, S., Wang, J., Zhang, S., Yin, T., Yang, C., & Yang, J. (2021). Extracellular vesicles derived from M1 macrophages deliver miR-146a-5p and miR-146b-5p to suppress trophoblast migration and invasion by targeting TRAF6 in recurrent spontaneous abortion. Theranostics, 11(12), 5813. https://doi.org/10.7150/thno.58731
  • Dutta, A., Roy, A., & Chatterjee, S. (2021). Long noncoding RNAs in cancer immunity: A new avenue in drug discovery. Drug Discovery Today, 26(1), 264–272.
  • El Khodiry, A., Afify, M., & El Tayebi, H. M. (2018). Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis. World Journal of Gastroenterology, 24(5), 549.
  • Ghafouri-Fard, S., Abak, A., Fattahi, F., Hussen, B. M., Bahroudi, Z., Shoorei, H., & Taheri, M. (2021). The interaction between miRnas/lncRnas and nuclear factor-κB (NF-κB) in human disorders. Biomedicine & Pharmacotherapy, 138(0753–3322), 111519.
  • Ghafouri-Fard, S., Hafez, A. A., & Taheri, M. (2020). Metastasis associated lung adenocarcinoma transcript 1: An update on expression pattern and functions in carcinogenesis. Experimental and Molecular Pathology, 112(0014–4800), 104330.
  • Han, D., Fang, Y., Guo, Y., Hong, W., Tu, J., & Wei, W. (2019). The emerging role of long non-coding RNAs in tumor-associated macrophages. Journal of Cancer, 10(26), 6738.
  • Heydarzadeh, S., Ranjbar, M., Karimi, F., Seif, F., & Alivand, M. R. (2021). Overview of host miRNA properties and their association with epigenetics, long non-coding RNAs, and xeno-infectious factors. Cell & Bioscience, 11(1), 1–17.
  • Huang, Y., Yan, Q., Yu, D., Sun, X., Jiang, S., Li, W., & Jia, L. (2021). Long intergenic non-protein coding RNA 960 regulates cancer cell viability, migration and invasion through modulating miR-146a-5p/interleukin 1 receptor associated kinase 1 axis in pancreatic ductal adenocarcinoma. Bioengineered, 12(1), 369–381.
  • Huang, X., Zhong, R., He, X., Deng, Q., Peng, X., Li, J., & Luo, X. (2019). Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRna‐146b‐5p mediated Wnt/β‐catenin signaling. IUBMB Life, 71(2), 223–234. https://doi.org/10.1002/iub.1959
  • Liu, M., Peng, Y., Che, Y., Zhou, M., Bai, Y., Tang, W., Huang, S., Zhang, B., Deng, S., Wang, C., & Yu, Z. (2022 Aug 24). MiR-146b-5p/traf6 axis is essential for ginkgo biloba L. extract GBE to attenuate LPS-induced neuroinflammation. Frontiers in Pharmacology, 13, 978587. https://doi.org/10.3389/fphar.2022.978587
  • O’neill, C. P., & Dwyer, R. M. (2020). Nanoparticle-based delivery of tumor suppressor microRNA for cancer therapy. Cells, 9(2), 521.
  • Stempor, P. A., Avni, D., Leibowitz, R., Sidi, Y., Stępień, M., Dzieciątkowski, T., & Dobosz, P. (2021). Comprehensive analysis of correlations in the expression of miRNA genes and immune checkpoint genes in bladder cancer cells. International Journal of Molecular Sciences, 22(5), 2553. https://doi.org/10.3390/ijms22052553
  • Tahamtan, A., Teymoori-Rad, M., Nakstad, B., & Salimi, V. (2018). Anti-inflammatory microRnas and their potential for inflammatory diseases treatment. Frontiers in Immunology, 9(1664–3224) , 1377.
  • Wang, C., Ke, S., Li, M., Lin, C., Liu, X., & Pan, Q. (2020). Downregulation of LncRNA GAS5 promotes liver cancer proliferation and drug resistance by decreasing PTEN expression. Molecular Genetics and Genomics, 295(1), 251–260.
  • Wang, C., Zhang, Q., Hu, Y., Zhu, J., & Yang, J. (2019). Emerging role of long noncoding RNA MALAT1 in predicting clinical outcomes of patients with digestive system malignancies: A metaanalysis. Oncology Letters, 17(2), 2159–2170. https://doi.org/10.3892/ol.2018.9875

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.